Return On Equity of Hoth Therapeutics, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Hoth Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Hoth Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -131%, a 48% decline year-over-year.
  • Hoth Therapeutics, Inc. annual Return On Equity for 2024 was -99%, a 36% decline from 2023.
  • Hoth Therapeutics, Inc. annual Return On Equity for 2023 was -73%, a 46% increase from 2022.
  • Hoth Therapeutics, Inc. annual Return On Equity for 2022 was -134%, a 40% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Hoth Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -131% -43% -48% 01 Jul 2025 30 Sep 2025
Q2 2025 -111% -31% -39% 01 Apr 2025 30 Jun 2025
Q1 2025 -105% -25% -32% 01 Jan 2025 31 Mar 2025
Q4 2024 -99% -26% -36% 01 Oct 2024 31 Dec 2024
Q3 2024 -88% +7% +7.6% 01 Jul 2024 30 Sep 2024
Q2 2024 -80% +27% +25% 01 Apr 2024 30 Jun 2024
Q1 2024 -80% +34% +30% 01 Jan 2024 31 Mar 2024
Q4 2023 -73% +62% +46% 01 Oct 2023 31 Dec 2023
Q3 2023 -95% +26% +21% 01 Jul 2023 30 Sep 2023
Q2 2023 -107% +7% +5.9% 01 Apr 2023 30 Jun 2023
Q1 2023 -114% -8% -7.6% 01 Jan 2023 31 Mar 2023
Q4 2022 -134% -39% -40% 01 Oct 2022 31 Dec 2022
Q3 2022 -121% -36% -42% 01 Jul 2022 30 Sep 2022
Q2 2022 -114% -24% -27% 01 Apr 2022 30 Jun 2022
Q1 2022 -106% -1% -1.1% 01 Jan 2022 31 Mar 2022
Q4 2021 -96% +37% +28% 01 Oct 2021 31 Dec 2021
Q3 2021 -85% +128% +60% 01 Jul 2021 30 Sep 2021
Q2 2021 -89% +127% +59% 01 Apr 2021 30 Jun 2021
Q1 2021 -105% +117% +53% 01 Jan 2021 31 Mar 2021
Q4 2020 -133% +57% +30% 01 Oct 2020 31 Dec 2020
Q3 2020 -213% -88% -71% 01 Jul 2020 30 Sep 2020
Q2 2020 -216% -90% -71% 01 Apr 2020 30 Jun 2020
Q1 2020 -221% -75% -51% 01 Jan 2020 31 Mar 2020
Q4 2019 -190% +45% +19% 01 Oct 2019 31 Dec 2019
Q3 2019 -125% 01 Jul 2019 30 Sep 2019
Q2 2019 -126% 01 Apr 2019 30 Jun 2019
Q1 2019 -147% 01 Jan 2019 31 Mar 2019
Q4 2018 -234% 01 Oct 2018 31 Dec 2018

Hoth Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -99% -26% -36% 01 Jan 2024 31 Dec 2024
2023 -73% +62% +46% 01 Jan 2023 31 Dec 2023
2022 -134% -39% -40% 01 Jan 2022 31 Dec 2022
2021 -96% +37% +28% 01 Jan 2021 31 Dec 2021
2020 -133% +57% +30% 01 Jan 2020 31 Dec 2020
2019 -190% +45% +19% 01 Jan 2019 31 Dec 2019
2018 -234% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.